Sanam Loghavi: CD123 Expression in AML To Assess CD123 Correlation with Genotype
Sanam Loghavi, Associate Professor of Pathology at MD Anderson Cancer Center, Medical Director of ECOG-ACRIN Leukemia Bank and Editor in Chief of Image Bank at the American Society of Hematology, shared a post on X about recent paper she and colleagues co-authored:
“Congrats Roberta Azevedo on her paper, out today in British Journal of Haematology.
She screened CD123 expression in AML to assess CD123 correlation with genotype. Timely as more anti-CD123 targeted therapies become available for AML patients.”
Title: CD123 expression and its correlation with mutation profile in acute myeloid leukaemia
Authors: Roberta S. Azevedo, Sa A. Wang, David M. Swanson, Naval G. Daver, Naveen Pemmaraju, Tapan M. Kadia, Ghayas C. Issa, Musa Yilmaz, Gautam Borthakur, Jayastu Senapati, Wei-Ying Jen, Nicholas J. Short, Farhad Ravandi, Wei Wang, Hong Fang, Jie Xu, Keyur P. Patel, Guilin Tang, L. Jeffrey Medeiros, Courtney D. DiNardo, Sanam Loghavi
Read The Full Article at British Journal of Haematology
More posts featuring Sanam Loghavi on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023